STRUCTURAL STUDY OF HEMATOLOGY-RELATED PROTEINS

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 我们利用X射线晶体学研究了在血液学领域中重要的蛋白质-蛋白质相互作用和蛋白质-膜相互作用。尿激酶纤溶酶原激活物（uPA）及其细胞表面受体（uPAR）在细胞表面介导多种生物活性，包括纤溶酶原激活、细胞外基质（ECM）重塑、生长因子激活和细胞内信号传导的启动。uPA系统已被认为在多种细胞功能中发挥重要作用，包括细胞粘附、迁移、侵袭和趋化性，特别是当它们涉及癌症和炎症中涉及的疾病过程时。uPA系统多效性的分子基础来自两个方面：1）uPAR与许多配体（包括uPA、玻连蛋白、整合素、低密度脂蛋白受体相关蛋白、G蛋白偶联受体等）相互作用的能力; 2）这些蛋白质-蛋白质相互作用引起的动态构象变化。通常无活性的单链uPA（scuPA）在与uPAR结合后产生酶活性。此外，scuPA和双链uPA（tcuPA）结合uPAR不同的纤溶酶原激活物抑制剂的敏感性，这表明它们的结构和调节的重要差异。我们的目标之一是系统地研究uPAR与其配体相互作用的结构基础和动力学性质

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. We use X-ray crystallography to study protein-protein interaction and protein-memberane interaction important in hematology field. Urokinase plasminogen activator (uPA) together with its cell surface receptor (uPAR) mediates a variety of biological activities at the cell surface including plasminogen activation, extracellular matrix (ECM) remodeling, growth factor activation and the initiation of intracellular signaling. The uPA system has been recognized as playing an important role in a variety of cellular functions, including cell adhesion, migration, invasion and chemotaxis, especially as they pertain to disease processes involved in cancer and inflammation. The molecular basis that underlies the pleiotropic activities of the uPA system stems from two aspects: 1) the ability of uPAR to interact with many ligands including uPA, vitronectin, integrins, low-density lipoprotein receptor-related protein, G-protein coupled receptor and others; 2) the dynamic conformational changes caused by these protein-protein interactions. Single-chain uPA (scuPA) that is usually inactive develops enzymatic activity upon binding with uPAR. Moreover, scuPA and two-chain uPA (tcuPA) bound to uPAR differ in their susceptibility to plasminogen activator inhibitors, suggesting important differences in their structure and regulation. One of our goals is to systematically study the structural basis and the dynamic nature of the interactions between uPAR and its ligands